rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

532321 CADILAHC Group (A)

Cadila Healthcare Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1285.00   13.85   1.09%
Volume 4,234
Prev close 1,271.15
Day's H/L (Rs.) 1,309.90 - 1,246.10
52wk H/L (Rs.) 1,326.45 - 650.00
Mkt Cap (Rs. Cr) 26,303.95
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

CADILAHC

Cadila Healthcare Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1290.35   17.50   1.37%
Volume 61,479
Prev close 1272.85
Day's H/L (Rs.) 1,312.80 - 1,272.05
52wk H/L (Rs.) 1,325.00 - 648.00
Turnover (Rs. Lacs) 796.29
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Cadila Healthcare Ltd.  (See all 178 market voices)   

140 Characters
  Cancel
Aayush - 20 hour(s) ago 90% ACCURACY HIGHLY PROFITABLE CALLS.ON A REAL-TIME BASIS TIMELY CALLS WITH PROPER TRADING RANGES, EXIT/ENTRY LEVELS AND BREAKOUT SIGNALS. PERSONALIZED 24X7 CUSTOMER SUPPORT. CALL 7509069109 OR VISIT http://rediff.ly/2xft7
#Cadila-Healthcare-Ltd
Reply   |   Share
Nisha Mondal - 3 day(s) ago Dear Traders/Investers do not go with rumours trade with only SEBI Registered investment adviser with proper risk & reward ratio for more information visit http://rediff.ly/37m87 and register
#Cadila-Healthcare-Ltd
Reply   |   Share

Realtime news for Cadila Healthcare Ltd. (See all 350 news)

16 September 2014, 10:49
Zydus Cadila gets USFDA nod for anti-hypertension drug - 30 Aug 2014
Cadila Healthcare consolidated net profit rises 23.15% in the June 2014 quarter - 26 Aug 2014
CADILA HEALTHCARE : Usfda raises concerns over production process at cadila - 04 Aug 2014
Cadila Healthcare corrects over 5% in two sessions - 01 Aug 2014
Cadila Healthcar - Zydus receives final approval for Telmisa... - 30 Aug 2014

BSE Announcements from Cadila Healthcare Ltd. (See all)

Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C - 1 day(s) ago
Zydus receives final approval for Telmisartan Tablets - 30 Aug 2014

Company details for Cadila Healthcare Ltd.

Report Card

PE Ratios
28.80
EPS (Rs.)
44.13
Sales (Rs. Cr)
1,112.79
Face Value (Rs.)
5
Net Profit
Margin (%)
 
20.76
Last Bonus
1:2
Last Dividend(%)
180
Return on
Average Equity
 
24.89

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Cadila Healthcare Ltd. performance snapshot

If you had invested Rs.  in Cadila Healthcare Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Cadila Healthcare Ltd. with other stocks

Piramal Enterprises Ltd.
739.40
GlaxoSmithKline Pharmaceuticals Ltd.
2,512.80
Show more companies
Piramal Enterprises Ltd.
739.40
GlaxoSmithKline Pharmaceuticals Ltd.
2,512.80
Dr. Reddy's Laboratories Ltd.
2,970.75
Glenmark Pharmaceuticals Ltd.
764.40
Ranbaxy Laboratories Ltd.
622.40
Strides Arcolab Ltd.
719.30
Divi's Laboratories Ltd.
1,716.55
Ipca Laboratories Ltd.
823.45
Wockhardt Ltd.
838.75
Biocon Ltd.
492.65
Show less companies
Close
Add Cadila Healthcare Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Cadila Healthcare Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close